Homocysteine levels in patients with risk factors for atherosclerosis

A Blum1, S Lupovitch, K Khazim

  • 1Department of Internal Medicine, Poria Hospital, Lower Galilee, Israel.

Clinical Cardiology
|June 14, 2001
PubMed

Insights

High homocysteine levels are common in patients with atherosclerosis risk factors. Measuring homocysteine is recommended for early detection and management of vascular disease risk.

Area of Science:

  • Cardiovascular Science
  • Metabolic Disorders
  • Epidemiology

Background:

  • Mild to moderate hyperhomocysteinemia is an established independent risk factor for atherosclerosis across various vascular beds.
  • Elevated plasma total homocysteine is a significant predictor of mortality in patients with confirmed coronary artery disease.

Purpose of the Study:

  • To assess homocysteine levels in individuals without diagnosed coronary artery disease but possessing at least one atherosclerosis risk factor.
  • To determine the prevalence of hyperhomocysteinemia in a population at risk for atherosclerotic vascular disease.

Main Methods:

  • Prospective collection of fasting blood samples from 160 consecutive patients (50 women, 110 men; mean age 65 years) with atherosclerosis risk factors but no documented coronary artery disease.
  • Homocysteine levels were quantified using a standard immunoassay method.

Main Results:

  • Nearly half (48.75%) of the patients studied exhibited elevated homocysteine levels.
  • Specifically, 62 patients presented with mild hyperhomocysteinemia (15-30 micromol/l), and 16 had moderate hyperhomocysteinemia (30-100 micromol/l).

Conclusions:

  • Hyperhomocysteinemia is highly prevalent in patients identified with risk factors for atherosclerosis.
  • Routine measurement and appropriate treatment of homocysteine levels are advised for patients with atherosclerosis risk factors due to its role as a modifiable risk factor.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...